0001437749-20-018608.txt : 20200824
0001437749-20-018608.hdr.sgml : 20200824
20200824164912
ACCESSION NUMBER: 0001437749-20-018608
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200820
FILED AS OF DATE: 20200824
DATE AS OF CHANGE: 20200824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Andrew D.
CENTRAL INDEX KEY: 0001811872
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33678
FILM NUMBER: 201128426
MAIL ADDRESS:
STREET 1: 2000 POWELL STREET
STREET 2: SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001389545
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680454536
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 899-8800
MAIL ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
rdgdoc.xml
FORM 4
X0306
4
2020-08-20
0001389545
NovaBay Pharmaceuticals, Inc.
NBY
0001811872
Jones Andrew D.
2000 POWELL STREET, SUITE 1150
EMERYVILLE
CA
94608
1
CFO
Stock Option (right to buy)
0.99
2020-08-20
4
A
0
25000
0
A
2021-08-20
2030-08-20
Common Stock
25000
25000
D
The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter.
/s/ Andrew D. Jones
2020-08-24